Sinopharm Holding GuoDa Drug Store Co., Ltd. Sustainability Profile
Sinopharm Holding GuoDa Drug Store Co., Ltd., commonly referred to as GuoDa, is a leading player in the pharmaceutical retail industry, headquartered in China. Established in 2000, the company has rapidly expanded its operations across major regions, including urban centres and rural areas, providing accessible healthcare solutions to millions. GuoDa specialises in the distribution of prescription medications, over-the-counter drugs, and health products, distinguished by its commitment to quality and customer service. The company has achieved significant milestones, including a vast network of retail outlets and a strong online presence, positioning itself as a trusted name in the market. With a focus on innovation and community health, GuoDa continues to enhance its product offerings, ensuring that it meets the evolving needs of consumers. Its notable achievements in the industry underscore its role as a key contributor to China's healthcare landscape.
DitchCarbon Score
How does Sinopharm Holding GuoDa Drug Store Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sinopharm Holding GuoDa Drug Store Co., Ltd.'s score of 43 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sinopharm Holding GuoDa Drug Store Co., Ltd., headquartered in China (CN), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Sinopharm Group Co. Ltd., which may influence its climate commitments and performance metrics. As of now, there are no documented reduction targets or climate pledges from Sinopharm Holding GuoDa Drug Store Co., Ltd. However, emissions data and performance metrics may be inherited from its parent company, Sinopharm Group Co. Ltd., which operates at a cascade level of 1. This means that any climate initiatives or emissions reductions may be aligned with the broader strategies of the parent organisation. In the context of the pharmaceutical retail industry, companies are increasingly focusing on sustainability and carbon footprint reduction. While specific initiatives or targets for Sinopharm Holding GuoDa Drug Store Co., Ltd. are not detailed, the industry trend suggests a growing commitment to addressing climate change and reducing greenhouse gas emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 30,741,540 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 88,611,470 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 000,000,000 |
How Carbon Intensive is Sinopharm Holding GuoDa Drug Store Co., Ltd.'s Industry?
How Carbon Intensive is Sinopharm Holding GuoDa Drug Store Co., Ltd.'s Location?
Sinopharm Holding GuoDa Drug Store Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sinopharm Holding GuoDa Drug Store Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
